Q1 2025 Management View CEO Celeste Mastin highlighted positive organic sales growth in Q1 2025, with a 1.9% year-over-year increase driven primarily by improving volume trends and moderate pricing ...
CEO Anderson expressed confidence in achieving double-digit adjusted EBITDA growth in 2025. CFO Sabrina Simmons outlined three financial priorities: gross margin expansion, SG&A leverage ...
“Nouryon’s 2024 full-year financial performance underscores the strength of our specialty portfolio, driving significant adjusted EBITDA growth and margin expansion," said Charlie ...